Skip to main content

and
  1. Article

    Open Access

    Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance

    Chronic myeloid leukemia (CML) is a myeloproliferative disorder associated with the Philadelphia chromosome, and the current standard of care is the use of tyrosine kinase inhibitors (TKI). However, some patie...

    Yi-Ying Wu, Hsing-Fan Lai, Tzu-Chuan Huang, Yu-Guang Chen in Cell Death & Disease (2021)